Jailed for Faking Data

A researcher working for a US pharmaceutical company’s Scotland branch is sent to prison for falsifying safety test data on experimental drugs due for clinical trials.

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, STEAKPINBALLA British scientist has this week (April 17) been sentenced to 3 months in prison for falsifying pre-clinical data for experimental drugs, reported The Daily Telegraph. It is the first time a researcher has been jailed under scientific regulation laws introduced in the United Kingdom in 1999.

Steven Eaton, who worked at US pharmaceutical company Aptuit’s site near Edinburgh, Scotland, performed liquid chromatography analyses to assess drug concentrations in blood, which helps to determine what doses of drug can safely be given to subjects in clinical trials. But in 2009, supervisors at Aptuit noticed irregularities in Eaton’s work and tipped off the Medicines and Healthcare Products Regulatory Agency (MHRA). The subsequent investigation found that since 2003, Eaton had been manipulating calibrations such that his analyses were flawed—and may have persuaded his colleagues that drugs were suitable for clinical trials when in fact they were not.

“Mr. Eaton’s actions directly impacted on the validity of clinical trials and delayed a number of medicines coming to market,” Gerald Heddell, director of inspection, enforcement, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies